These findings have implications of relevance, regarding both the complex metabolic phenotypes displayed in caveolinopathies and the physiopathological role and therapeutic potential of CAV1 in multiple complex diseases that potentially course with MAM aberrant functioning, such as diabetes, obesity, hepatosteatosis and cancer. This evidence concerns the gene CAV1 and caveolinopathy.